Kymera Therapeutics, Inc. · Brief

Next report

72 days

Jan 12 · before openest.Q4 FY26

Earnings

Expected move

Inputs

±39.9%implied · report alone

76.11177.15

straddle ±43.5%

spot 126.63exp Jan 15ATM strike 125ATM straddle 64.75IV 143%

Oct 30 closereport share · term structure

Expected move

Inputs

Implied vs realized

8 reportsHistory

1 of 8≥ implied

avg implied: ±11.1%
avg realized: ±2.2%

May 9 '25±10.6%▼−2.27%×0.22

Aug 11 '25±6.2%▼−7.24%×1.16

Q3 FY25±15.7%▲+0.32%×0.02

Jan 13 '26±5.5%▲+1.42%×0.26

Feb 26 '26±11.8%▲+4.80%×0.41

Q1 FY26±10.3%▼−0.54%×0.05

Q2 FY26±10.4%▲+1.04%×0.10

Q3 FY26±18.2%▲+0.07%×0.00

quarterimplied−20%0+20%realized×

Q3 FY26±18.2%▲+0.07%×0.00

Q2 FY26±10.4%▲+1.04%×0.10

Q1 FY26±10.3%▼−0.54%×0.05

Feb '26±11.8%▲+4.80%×0.41

Jan '26±5.5%▲+1.42%×0.26

Q3 FY25±15.7%▲+0.32%×0.02

2 older reports

Aug '25±6.2%▼−7.24%×1.16

May '25±10.6%▼−2.27%×0.22

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Jan 12 report · est.

—

Linked exposure

KYMR report session

No linked exposure.

Latest changes

30 daysAll changes

Oct 28impliedImplied move: ±18.2% into Oct 29 earnings (Oct 28 close).Source

Oct 20impliedImplied move: ±20.0% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.